Literature DB >> 19406756

Adolescent and caregiver experiences with epilepsy.

Miya R Asato1, Ranjani Manjunath, Raj D Sheth, Stephanie J Phelps, James W Wheless, Collin A Hovinga, Jesus E Pina-Garza, Lisa S Haskins, Wendy M Zingaro.   

Abstract

Epilepsy during adolescence can impede the development of psychosocial independence and typical biological maturational processes. We examined in parallel the experiences and perceptions of adolescent patients with epilepsy and their caregivers. Specifically, we focused on frequency and type of seizures, comorbid conditions, adherence to therapies, productivity, clinical and quality of life consequences of seizures, estimated use and content of seizure emergency plans, and the patient-physician relationship. Two cross-sectional online surveys were conducted among 153 adolescent patients with epilepsy and their respective caregivers. A total of 35% of adolescents indicated that they had been nonadherent to antiepileptic medications in the prior month. Adolescents scored significantly lower compared with their peers on quality-of-life measures. Adolescents and caregivers reported similarly on nearly all domains. An adolescent-centered epilepsy management program may help alleviate concerns and also help the adolescent independently manage their epilepsy as they transition into adulthood.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406756     DOI: 10.1177/0883073809332396

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  14 in total

1.  Development and validation of the Pediatric Epilepsy Medication Self-Management Questionnaire.

Authors:  Avani C Modi; Sally Monahan; Dee Daniels; Tracy A Glauser
Journal:  Epilepsy Behav       Date:  2010-05-08       Impact factor: 2.937

2.  Commentary: Pediatric epilepsy: a good fit for pediatric psychologists.

Authors:  Janelle L Wagner; Avani Modi; Gigi Smith
Journal:  J Pediatr Psychol       Date:  2010-12-08

3.  Allocation of Treatment Responsibility in Adolescents With Epilepsy: Associations With Cognitive Skills and Medication Adherence.

Authors:  Christina E Holbein; Aimee W Smith; James Peugh; Avani C Modi
Journal:  J Pediatr Psychol       Date:  2019-01-01

4.  Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy.

Authors:  Avani C Modi; Shanna M Guilfoyle; Diego A Morita; Tracy A Glauser
Journal:  Epilepsia       Date:  2010-11-18       Impact factor: 5.864

5.  Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy.

Authors:  Avani C Modi; Joseph R Rausch; Tracy A Glauser
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

6.  Treatment adherence among adolescents with epilepsy: what really matters?

Authors:  Loretta Carbone; Bradley Zebrack; Melissa Plegue; Sucheta Joshi; Renée Shellhaas
Journal:  Epilepsy Behav       Date:  2013-01-31       Impact factor: 2.937

7.  The development of a social norms adherence intervention for adolescents with epilepsy.

Authors:  Avani C Modi; Anup D Patel; Ana M Gutierrez-Colina; Sara E Wetter; Leah M Heckaman; Andrea Debs; Constance A Mara; Evelynne Wentzel; Matthew Schmidt; Jack Stevens
Journal:  Epilepsy Behav       Date:  2020-12-09       Impact factor: 2.937

8.  Social brain networks: Resting-state and task-based connectivity in youth with and without epilepsy.

Authors:  M Morningstar; R C French; W I Mattson; D J Englot; E E Nelson
Journal:  Neuropsychologia       Date:  2021-05-05       Impact factor: 3.054

9.  Caregiver burden in epilepsy: determinants and impact.

Authors:  Ioannis Karakis; Andrew J Cole; Georgia D Montouris; Marta San Luciano; Kimford J Meador; Charitomeni Piperidou
Journal:  Epilepsy Res Treat       Date:  2014-04-08

10.  Social Behavioral Problems and the Health-Related Quality of Life in Children and Adolescents with Epilepsy.

Authors:  Hee-Yeon Choi; Song E Kim; Hyang Woon Lee; Eui-Jung Kim
Journal:  Psychiatry Investig       Date:  2016-09-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.